Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1096629

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1096629

NA IVD Regulatory Affairs Outsourcing Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 211 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

North America IVD regulatory affairs outsourcing market is projected to register a CAGR of 13.4% in the forecast period of 2022 to 2029. The new market report contains data for historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:

North America IVD Regulatory Affairs Outsourcing Market, By Service (Regulatory Writing & Submissions, Regulatory Registration & Clinical Trial Applications, Regulatory Consulting, Legal Representation, Data Management Services, Chemistry Manufacturing and Controls (CMC) Services, and Others), Indication (Oncology, Neurology, Cardiology, Clinical Chemistry And Immunoassays, Precision Medicine, Infectious Diseases, Diabetes, Genetic Testing, HIV/Aids, Haematology, Drug Testing/Pharmacogenomics, Blood Transfusion, Point Of Care, and Others), Deployment Model (Cloud and On-Premises), Organization Size (Small and Medium Enterprises (SMES) and Large Enterprises), Stage (Clinical, Preclinical, and PMA (Post-Market Authorization)), Class (Class I, Class II, and Class III), End User (Pharmaceutical Companies, Medical Device Companies, Biotechnology Companies, and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the North America IVD regulatory affairs outsourcing market are:

Rise in prevalence of chronic diseases across the region is expected to drive the growth of the market

Technological advancements in various in vitro diagnostic devices is also expected to accelerate the growth

Market Players

Some of the major players operating in the IVD regulatory affairs outsourcing market are:

Freyr Solutions

AXSource

LORENZ Life Sciences Group

PPD Inc. (A Subsidiary of Thermofisher Scientific Inc.)

Promedica International

Assent Compliance Inc.

MakroCare

EMERGO

ICON

Parexel International Corporation

CRITERIUM, INC.

Groupe ProductLife S.A

Propharma Group

VCLS

Labcorp Drug Development

WuXi AppTec

Charles River Laboratories

Genpact

Medpace

Regulatory Compliance Associates Inc.

RQM+

Saraca Solutions Private Limited

PBC BioMed

Dor Pharmaceutical Services

Qserve

mdiConsultants, Inc.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 DBMR MARKET POSITION GRID
  • 2.7 VENDOR SHARE ANALYSIS
  • 2.8 MULTIVARIATE MODELING
  • 2.9 SERVICE TIMELINE CURVE
  • 2.10 MARKET END USER COVERAGE GRID
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, REGULATORY SCENARIO
    • 4.1.1 THE U.S.
    • 4.1.2 REGULATIONS IN EUROPE
    • 4.1.3 REGULATIONS IN ASIA
      • 4.1.3.1 CHINA
      • 4.1.3.2 SOUTH KOREA
      • 4.1.3.3 MALAYSIA
      • 4.1.3.4 THAILAND

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES ACROSS THE REGION
    • 5.1.2 TECHNOLOGICAL ADVANCEMENT IN DEVELOPING VARIOUS IN VITRO DIAGNOSTIC DEVICES
    • 5.1.3 DEVELOPMENT OF PROJECT-BASED SUPPORT LEADS TO LONG TERM OUTSOURCING AGREEMENT AMONG ORGANIZATION
    • 5.1.4 INCREASE IN PRODUCT REGISTRATION NUMBERS AND CLINICAL TRIAL APPROVALS ACROSS THE REGION
  • 5.2 RESTRAINTS
    • 5.2.1 STRINGENT REGULATIONS REGARDING MEDICAL DEVICES IN DIFFERENT REGIONS
    • 5.2.2 HIGHER COST RELATED TO MAINTENANCE AND OUTSOURCING OF IVD
  • 5.3 OPPORTUNITIES
    • 5.3.1 RISE IN STRATEGIC ACQUISITION & PARTNERSHIP AMONG ORGANIZATION
    • 5.3.2 EMERGENCE OF VARIOUS EFFICIENT TECHNOLOGICAL SERVICES AND STANDARDS
    • 5.3.3 INCREASE IN R&D ACTIVITIES BY COMPANIES ACROSS THE REGION
  • 5.4 CHALLENGES
    • 5.4.1 LACK OF INFRASTRUCTURE IN HEALTHCARE SERVICE
    • 5.4.2 SHORTAGE OF SKILLED PERSONNEL FOR HANDLING IN VITRO DIAGNOSTIC DEVICES

6 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE

  • 6.1 OVERVIEW
  • 6.2 REGULATORY WRITING & SUBMISSIONS
  • 6.3 LEGAL REPRESENTATION
  • 6.4 REGULATORY CONSULTING
  • 6.5 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS
  • 6.6 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES
  • 6.7 DATA MANAGEMENT SERVICES
  • 6.8 OTHERS

7 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION

  • 7.1 OVERVIEW
  • 7.2 CLINICAL CHEMISTRY AND IMMUNOASSAYS
  • 7.3 INFECTIOUS DISEASES
    • 7.3.1 VIROLOGY
    • 7.3.2 MICROBIOLOGY AND MYCOLOGY
    • 7.3.3 BACTERIOLOGY
    • 7.3.4 SEPSIS
    • 7.3.5 HEPATITIS B
    • 7.3.6 HEPATITIS C
    • 7.3.7 MALARIA
    • 7.3.8 TUBERCULOSIS
    • 7.3.9 SYPHILIS
    • 7.3.10 HUMAN PAPILLOMAVIRUS (HPV) INFECTION
    • 7.3.11 OTHERS
  • 7.4 HAEMATOLOGY
  • 7.5 DRUG TESTING/PHARMACOGENOMICS
  • 7.6 PRECISION MEDICINE
  • 7.7 DIABETES
  • 7.8 BLOOD TRANSFUSION
  • 7.9 CARDIOLOGY
  • 7.10 POINT OF CARE
    • 7.10.1 WAIVED TEST
    • 7.10.2 AT HOME TESTS
  • 7.11 ONCOLOGY
  • 7.12 NEUROLOGY
  • 7.13 HIV/AIDS
  • 7.14 GENETIC TESTING
  • 7.15 OTHERS

8 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS

  • 8.1 OVERVIEW
  • 8.2 CLASS I
  • 8.3 CLASS III
  • 8.4 CLASS II

9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE

  • 9.1 OVERVIEW
  • 9.2 CLOUD
  • 9.3 ON-PREMISES

10 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE

  • 10.1 OVERVIEW
  • 10.2 LARGE ENTERPRISES
  • 10.3 SMALL & MEDIUM ENTERPRISES (SMES)

11 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE

  • 11.1 OVERVIEW
  • 11.2 CLINICAL
  • 11.3 PRECLINICAL
  • 11.4 PMA (POST MARKET AUTHORIZATION)

12 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER

  • 12.1 OVERVIEW
  • 12.2 MEDICAL DEVICE COMPANIES
    • 12.2.1 BY ORGANIZATION SIZE
      • 12.2.1.1 LARGE ENTERPRISES
      • 12.2.1.2 SMALL & MEDIUM ENTERPRISES (SMES)
    • 12.2.2 BY SERVICE
      • 12.2.2.1 REGULATORY WRITING & SUBMISSIONS
      • 12.2.2.2 LEGAL REPRESENTATION
      • 12.2.2.3 REGULATORY CONSULTING
      • 12.2.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS
      • 12.2.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES
      • 12.2.2.6 DATA MANAGEMENT SERVICES
      • 12.2.2.7 OTHERS
  • 12.3 PHARMACEUTICAL COMPANIES
    • 12.3.1 BY ORGANIZATION SIZE
      • 12.3.1.1 LARGE ENTERPRISES
      • 12.3.1.2 SMALL & MEDIUM ENTERPRISES (SMES)
    • 12.3.2 BY SERVICE
      • 12.3.2.1 REGULATORY WRITING & SUBMISSIONS
      • 12.3.2.2 LEGAL REPRESENTATION
      • 12.3.2.3 REGULATORY CONSULTING
      • 12.3.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS
      • 12.3.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES
      • 12.3.2.6 DATA MANAGEMENT SERVICES
      • 12.3.2.7 OTHERS
  • 12.4 BIOTECHNOLOGY COMPANIES
    • 12.4.1 BY ORGANIZATION SIZE
      • 12.4.1.1 LARGE ENTERPRISES
      • 12.4.1.2 SMALL & MEDIUM ENTERPRISES (SMES)
    • 12.4.2 BY SERVICE
      • 12.4.2.1 REGULATORY WRITING & SUBMISSIONS
      • 12.4.2.2 LEGAL REPRESENTATION
      • 12.4.2.3 REGULATORY CONSULTING
      • 12.4.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS
      • 12.4.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES
      • 12.4.2.6 DATA MANAGEMENT SERVICES
      • 12.4.2.7 OTHERS
  • 12.5 OTHERS

13 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION

  • 13.1 NORTH AMERICA
    • 13.1.1 U.S.
    • 13.1.2 CANADA
    • 13.1.3 MEXICO

14 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY LANDSCAPE

  • 14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

  • 16.1 ICON PLC
    • 16.1.1 COMPANY SNAPSHOT
    • 16.1.2 REVENUE ANALYSIS
    • 16.1.3 COMPANY SHARE ANALYSIS
    • 16.1.4 PRODUCT PORTFOLIO
    • 16.1.5 RECENT DEVELOPMENTS
  • 16.2 MEDPACE
    • 16.2.1 COMPANY SNAPSHOT
    • 16.2.2 REVENUE ANALYSIS
    • 16.2.3 COMPANY SHARE ANALYSIS
    • 16.2.4 PRODUCT PORTFOLIO
    • 16.2.5 RECENT DEVELOPMENTS
  • 16.3 PAREXEL INTERNATIONAL CORPORATION
    • 16.3.1 COMPANY SNAPSHOT
    • 16.3.2 COMPANY SHARE ANALYSIS
    • 16.3.3 PRODUCT PORTFOLIO
    • 16.3.4 RECENT DEVELOPMENTS
  • 16.4 LABCORP DRUG DEVELOPMENT
    • 16.4.1 COMPANY SNAPSHOT
    • 16.4.2 REVENUE ANALYSIS
    • 16.4.3 COMPANY SHARE ANALYSIS
    • 16.4.4 PRODUCT PORTFOLIO
    • 16.4.5 RECENT DEVELOPMENT
  • 16.5 PPD INC. (A SUBSIDIARY OF THERMOFISHER SCIENTIFIC INC.)
    • 16.5.1 COMPANY SNAPSHOT
    • 16.5.2 COMPANY SHARE ANALYSIS
    • 16.5.3 PRODUCT PORTFOLIO
    • 16.5.4 RECENT DEVELOPMENTS
  • 16.6 CHARLES RIVER LABORATORIES
    • 16.6.1 COMPANY SNAPSHOT
    • 16.6.2 REVENUE ANALYSIS
    • 16.6.3 PRODUCT PORTFOLIO
    • 16.6.4 RECENT DEVELOPMENTS
  • 16.7 FREYR
    • 16.7.1 COMPANY SNAPSHOT
    • 16.7.2 PRODUCT PORTFOLIO
    • 16.7.3 RECENT DEVELOPMENTS
  • 16.8 ASSENT COMPLIANCE INC.
    • 16.8.1 COMPANY SNAPSHOT
    • 16.8.2 PRODUCT PORTFOLIO
    • 16.8.3 RECENT DEVELOPMENT
  • 16.9 ANDAMAN MEDICAL
    • 16.9.1 COMPANY SNAPSHOT
    • 16.9.2 PRODUCT PORTFOLIO
    • 16.9.3 RECENT DEVELOPMENT
  • 16.10 ASIA ACTUAL
    • 16.10.1 COMPANY SNAPSHOT
    • 16.10.2 SERVICE PORTFOLIO
    • 16.10.3 RECENT DEVELOPMENTS
  • 16.11 AXSOURCE
    • 16.11.1 COMPANY SNAPSHOT
    • 16.11.2 PRODUCT PORTFOLIO
    • 16.11.3 RECENT DEVELOPMENTS
  • 16.12 CRITERIUM, INC.
    • 16.12.1 COMPANY SNAPSHOT
    • 16.12.2 PRODUCT PORTFOLIO
    • 16.12.3 RECENT DEVELOPMENT
  • 16.13 DOR PHARMACEUTICAL SERVICES
    • 16.13.1 COMPANY SNAPSHOT
    • 16.13.2 SERVICE PORTFOLIO
    • 16.13.3 RECENT DEVELOPMENTS
  • 16.14 EMERGO BY UL
    • 16.14.1 COMPANY SNAPSHOT
    • 16.14.2 PRODUCT PORTFOLIO
    • 16.14.3 RECENT DEVELOPMENTS
  • 16.15 GENPACT
    • 16.15.1 COMPANY SNAPSHOT
    • 16.15.2 REVENUE ANALYSIS
    • 16.15.3 PRODUCT PORTFOLIO
    • 16.15.4 RECENT DEVELOPMENTS
  • 16.16 GROUPE PRODUCTLIFE S.A.
    • 16.16.1 COMPANY SNAPSHOT
    • 16.16.2 PRODUCT PORTFOLIO
    • 16.16.3 RECENT DEVELOPMENTS
  • 16.17 LORENZ LIFE SCIENCES GROUP
    • 16.17.1 COMPANY SNAPSHOT
    • 16.17.2 PRODUCT PORTFOLIO
    • 16.17.3 RECENT DEVELOPMENTS
  • 16.18 MAKROCARE
    • 16.18.1 COMPANY SNAPSHOT
    • 16.18.2 PRODUCT PORTFOLIO
    • 16.18.3 RECENT DEVELOPMENTS
  • 16.19 MARACA INTERNATIONAL BVBA
    • 16.19.1 COMPANY SNAPSHOT
    • 16.19.2 SERVICE PORTFOLIO
    • 16.19.3 RECENT DEVELOPMENTS
  • 16.20 MDICONSULTANTS, INC.
    • 16.20.1 COMPANY SNAPSHOT
    • 16.20.2 PRODUCT PORTFOLIO
    • 16.20.3 RECENT DEVELOPMENTS
  • 16.21 PBC BIOMED
    • 16.21.1 COMPANY SNAPSHOT
    • 16.21.2 PRODUCT PORTFOLIO
    • 16.21.3 RECENT DEVELOPMENT
  • 16.22 PROMEDICA INTERNATIONAL, A CALIFORNIA CORPORATION
    • 16.22.1 COMPANY SNAPSHOT
    • 16.22.2 PRODUCT PORTFOLIO
    • 16.22.3 RECENT DEVELOPMENT
  • 16.23 PROPHARMA GROUP
    • 16.23.1 COMPANY SNAPSHOT
    • 16.23.2 PRODUCT PORTFOLIO
    • 16.23.3 RECENT DEVELOPMENTS
  • 16.24 QSERVE
    • 16.24.1 COMPANY SNAPSHOT
    • 16.24.2 SERVICE PORTFOLIO
    • 16.24.3 RECENT DEVELOPMENTS
  • 16.25 REGULATORY COMPLIANCE ASSOCIATES INC.
    • 16.25.1 COMPANY SNAPSHOT
    • 16.25.2 PRODUCT PORTFOLIO
    • 16.25.3 RECENT DEVELOPMENT
  • 16.26 RMQ+
    • 16.26.1 COMPANY SNAPSHOT
    • 16.26.2 PRODUCT PORTFOLIO
    • 16.26.3 RECENT DEVELOPMENT
  • 16.27 SARACA SOLUTIONS PRIVATE LIMITED
    • 16.27.1 COMPANY SNAPSHOT
    • 16.27.2 PRODUCT PORTFOLIO
    • 16.27.3 RECENT DEVELOPMENT
  • 16.28 VCLS
    • 16.28.1 COMPANY SNAPSHOT
    • 16.28.2 PRODUCT PORTFOLIO
    • 16.28.3 RECENT DEVELOPMENTS
  • 16.29 WUXI APPTEC
    • 16.29.1 COMPANY SNAPSHOT
    • 16.29.2 REVENUE ANALYSIS
    • 16.29.3 PRODUCT PORTFOLIO
    • 16.29.4 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 57
  • TABLE 2 NORTH AMERICA REGULATORY WRITING & SUBMISSIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 57
  • TABLE 3 NORTH AMERICA LEGAL REPRESENTATION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 58
  • TABLE 4 NORTH AMERICA REGULATORY CONSULTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 58
  • TABLE 5 NORTH AMERICA REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 59
  • TABLE 6 NORTH AMERICA CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 60
  • TABLE 7 NORTH AMERICA DATA MANAGEMENT SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY MATERIAL, 2020-2029 (USD THOUSAND) 60
  • TABLE 8 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 61
  • TABLE 9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND) 65
  • TABLE 10 NORTH AMERICA CLINICAL CHEMISTRY AND IMMUNOASSAYS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 66
  • TABLE 11 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION,2020-2029 (THOUSAND) 66
  • TABLE 12 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 67
  • TABLE 13 NORTH AMERICA HAEMATOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 69
  • TABLE 14 NORTH AMERICA DRUG TESTING/PHARMACOGENOMICS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 69
  • TABLE 15 NORTH AMERICA PRECISION MEDICINE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 70
  • TABLE 16 NORTH AMERICA DIABETES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 70
  • TABLE 17 NORTH AMERICA BLOOD TRANSFUSION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 71
  • TABLE 18 NORTH AMERICA CARDIOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 72
  • TABLE 19 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 72
  • TABLE 20 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 73
  • TABLE 21 NORTH AMERICA ONCOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 73
  • TABLE 22 NORTH AMERICA NEUROLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 74
  • TABLE 23 NORTH AMERICA HIV/AIDS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 75
  • TABLE 24 NORTH AMERICA GENETIC TESTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 75
  • TABLE 25 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 76
  • TABLE 26 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND) 79
  • TABLE 27 NORTH AMERICA CLASS I IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 79
  • TABLE 28 NORTH AMERICA CLASS III IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND) 80
  • TABLE 29 NORTH AMERICA CLASS II IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 80
  • TABLE 30 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND) 83
  • TABLE 31 NORTH AMERICA CLOUD IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 83
  • TABLE 32 NORTH AMERICA ON-PREMISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 84
  • TABLE 33 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND) 87
  • TABLE 34 NORTH AMERICA LARGE ENTERPRISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 87
  • TABLE 35 NORTH AMERICA SMALL & MEDIUM ENTERPRISES (SMES) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 88
  • TABLE 36 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND) 91
  • TABLE 37 NORTH AMERICA CLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 91
  • TABLE 38 NORTH AMERICA PRECLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 92
  • TABLE 39 NORTH AMERICA PMA (POST MARKET AUTHORIZATION) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 92
  • TABLE 40 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND) 95
  • TABLE 41 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 95
  • TABLE 42 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 96
  • TABLE 43 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 96
  • TABLE 44 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 98
  • TABLE 45 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 98
  • TABLE 46 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 99
  • TABLE 47 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 100
  • TABLE 48 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 101
  • TABLE 49 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 101
  • TABLE 50 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND) 103
  • TABLE 51 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND) 109
  • TABLE 52 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 109
  • TABLE 53 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND) 110
  • TABLE 54 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 110
  • TABLE 55 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 111
  • TABLE 56 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND) 111
  • TABLE 57 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 111
  • TABLE 58 NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND) 111
  • TABLE 59 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND) 111
  • TABLE 60 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND) 112
  • TABLE 61 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 112
  • TABLE 62 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 112
  • TABLE 63 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 113
  • TABLE 64 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 113
  • TABLE 65 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 113
  • TABLE 66 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 114
  • TABLE 67 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 115
  • TABLE 68 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND) 115
  • TABLE 69 U.S. INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 116
  • TABLE 70 U.S. POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 116
  • TABLE 71 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND) 116
  • TABLE 72 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 116
  • TABLE 73 U.S. REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND) 117
  • TABLE 74 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND) 117
  • TABLE 75 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND) 117
  • TABLE 76 U.S. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 117
  • TABLE 77 U.S. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 118
  • TABLE 78 U.S. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 118
  • TABLE 79 U.S. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 118
  • TABLE 80 U.S. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 119
  • TABLE 81 U.S. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 119
  • TABLE 82 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 120
  • TABLE 83 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND) 120
  • TABLE 84 CANADA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 121
  • TABLE 85 CANADA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 121
  • TABLE 86 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND) 121
  • TABLE 87 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 121
  • TABLE 88 CANADA REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND) 122
  • TABLE 89 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND) 122
  • TABLE 90 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND) 122
  • TABLE 91 CANADA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 122
  • TABLE 92 CANADA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 123
  • TABLE 93 CANADA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 123
  • TABLE 94 CANADA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 123
  • TABLE 95 CANADA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 124
  • TABLE 96 CANADA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 124
  • TABLE 97 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 125
  • TABLE 98 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND) 125
  • TABLE 99 MEXICO INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 126
  • TABLE 100 MEXICO POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 126
  • TABLE 101 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND) 126
  • TABLE 102 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 126
  • TABLE 103 MEXICO REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND) 127
  • TABLE 104 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND) 127
  • TABLE 105 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND) 127
  • TABLE 106 MEXICO MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 127
  • TABLE 107 MEXICO MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 128
  • TABLE 108 MEXICO PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 128
  • TABLE 109 MEXICO PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 128
  • TABLE 110 MEXICO BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND) 129
  • TABLE 111 MEXICO BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND) 129

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION 25
  • FIGURE 2 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DATA TRIANGULATION 28
  • FIGURE 3 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DROC ANALYSIS 29
  • FIGURE 4 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 30
  • FIGURE 5 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY RESEARCH ANALYSIS 30
  • FIGURE 6 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: INTERVIEW DEMOGRAPHICS 31
  • FIGURE 7 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DBMR MARKET POSITION GRID 32
  • FIGURE 8 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: VENDOR SHARE ANALYSIS 34
  • FIGURE 9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: END USER COVERAGE GRID 36
  • FIGURE 10 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION 40
  • FIGURE 11 RISE IN THE PREVALENCE OF CHRONIC DISEASES ACROSS IS EXPECTED TO DRIVE NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 41
  • FIGURE 12 SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN 2022 & 2029 41
  • FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE AND IS THE FASTEST GROWING REGION IN THE NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 42
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET 47
  • FIGURE 15 MULTIPLE CHRONIC CONDITIONS AMONG PEOPLE AGED 65 AND ABOVE IN EUROPEAN REGION (2017) 48
  • FIGURE 16 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE, 2021 55
  • FIGURE 17 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY INDICATION, 2021 63
  • FIGURE 18 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY CLASS, 2021 77
  • FIGURE 19 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY DEPLOYMENT MODE, 2021 81
  • FIGURE 20 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY ORGANIZATION SIZE, 2021 85
  • FIGURE 21 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY STAGE, 2021 89
  • FIGURE 22 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY END USER, 2021 93
  • FIGURE 23 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SNAPSHOT (2021) 104
  • FIGURE 24 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021) 106
  • FIGURE 25 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2022 & 2029) 106
  • FIGURE 26 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021 & 2029) 107
  • FIGURE 27 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE (2022-2029) 107
  • FIGURE 28 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY SHARE 2021 (%) 129
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!